Phytochemical Constituents of Medicinal Plants for the Treatment of Chronic Inflammation
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 87317
Special Issue Editor
Interests: diabetic complications; NASH; IBD; Toll-like receptor signal pathway; innate immunity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chronic inflammation increases the risk of several serious human diseases. Plant-derived phytochemicals have emerged as novel agents for protecting against chronic disorders. Owing to the diversity of phytochemicals, they cover a wide spectrum of therapeutic indications against cancer, inflammation and neurodegenerative diseases and have been a productive source of lead compounds for the development of novel medications. An important direction for future investigation is to further optimize the basic experiments to predict clinical results. Combinatorial strategies which target multiple mechanisms, such as increasing anti-inflammatory efficacy and triggering a response of innate immune system, may offer the better chance for clinically meaningful prevention. This special issue aims to identify lead compounds for inflammation-related diseases through in-depth mechanism studies of medicinal plant components.
Dr. Ki Sung Kang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Bioactive natural compounds
- Chronic inflammation
- Mucosal immune response
- Intracellular signal pathways
- Innate immune
- Host-microbe interaction
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.